Get the Stockscreener App
1.52
3.18%
-0.05
MAIA Biotechnology Inc stock is traded at $1.52, with a volume of 236.09K.
It is down -3.18% in the last 24 hours and down -20.83% over the past month.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.
See More
Previous Close:
$1.57
Open:
$1.55
24h Volume:
236.09K
Relative Volume:
0.55
Market Cap:
$46.07M
Revenue:
-
Net Income/Loss:
$-25.94M
P/E Ratio:
-1.1014
EPS:
-1.38
Net Cash Flow:
$-15.79M
1W Performance:
-10.59%
1M Performance:
-20.83%
6M Performance:
-19.15%
1Y Performance:
-50.97%
1-Day Range:
$1.47
$1.55
1-Week Range:
$1.47
$1.885
52-Week Range:
$1.40
$3.742
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Name
MAIA Biotechnology Inc
Sector
Industry
Phone
312 416 8592
Address
444 West Lake Street, Suite 1700, Chicago
Compare MAIA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.52 | 48.31M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
MAIA Biotechnology Inc Stock (MAIA) Latest News
What catalysts could drive MAIA Biotechnology Inc. stock higher in 2025AI Powered Report For Fast Growth - jammulinksnews.com
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
What are analysts’ price targets for MAIA Biotechnology Inc. in the next 12 monthsBest Dividend Entry Points For Every Investor - jammulinksnews.com
How volatile is MAIA Biotechnology Inc. stock compared to the marketSwing Trade Entry Points For Fast Growth - jammulinksnews.com
Does MAIA Biotechnology Inc. stock perform well during market downturnsTop Growth Alerts With Proven Results - jammulinksnews.com
Why is MAIA Biotechnology Inc. stock attracting strong analyst attentionValue Investing Recommendation For Consistent Profits - jammulinksnews.com
What are the latest earnings results for MAIA Biotechnology Inc.Daily Trading Picks Backed By Experts - jammulinksnews.com
What institutional investors are buying MAIA Biotechnology Inc. stockRetirement Planning Entry Points For Every Investor - jammulinksnews.com
Buy Signal for MAIA Biotechnology Inc. Stock Key Technical Indicators to WatchConservative Long Term Growth Plans Under Review - beatles.ru
Maia Biotechnology shares jump after FDA awards Fast Track status - MSN
Can MAIA Biotechnology Inc. recover in the next quarterTrade Timing Strategy With Technical Data Explained - metal.it
Will MAIA Biotechnology Inc. benefit from macro trendsPredictive AI Engine for Smart Investing - Newser
Key resistance and support levels for MAIA Biotechnology Inc.Real-Time AI Sentiment and Price Forecast - Newser
RSI Crosses Above 30 for MAIA Biotechnology Inc. — Reversal in SightWeekly Watchlist of High Movers Released - metal.it
Is MAIA Biotechnology Inc. stock a growth or value playSector Rotation Outlook With Historical Summary - Newser
Why MAIA Biotechnology Inc. stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it
How to escape a deep drawdown in MAIA Biotechnology Inc.Asset Growth Pattern and Return Summary - Newser
Using RSI to spot recovery in MAIA Biotechnology Inc.Weekly Hot Stocks Based on Volume Flow - Newser
Will MAIA Biotechnology Inc. Hold Gains Into CloseShort Term High Yield Stock Tips for Active Traders - metal.it
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine - Contract Pharma
MAIA Biotechnology’s Ateganosine Receives FDA Fast Track - TipRanks
MAIA Biotechnology and the Ateganosine Opportunity in NSCLC: Assessing the Fast Track Designation as a Catalyst for Accelerated Value Creation in a High-Growth Oncology Market - AInvest
Maia Biotechnology receives FDA's fast track designation for Ateganosine as a treatment for non-small cell lung cancer - MarketScreener
Maia Biotechnology stock soars after FDA grants Fast Track designation - Investing.com Australia
Maia Biotechnology stock soars after FDA grants Fast Track designation By Investing.com - Investing.com South Africa
MAIA Biotechnology Announces FDA Fast Track For First-in-Class Telomere-Targeting Drug In NSCLC; Latest Data In Pivotal Phase 2 THIO-101 Clinical Trial Shows Median Overall Survival Of 17.8 Months - 富途牛牛
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer - Business Wire
What makes MAIA Biotechnology Inc. stock price move sharplyInvest confidently with proven investment plans - jammulinksnews.com
What is the dividend policy of MAIA Biotechnology Inc. stockAchieve breakthrough gains with expert advice - jammulinksnews.com
When is MAIA Biotechnology Inc. stock expected to show significant growth - jammulinksnews.com
Should I hold or sell MAIA Biotechnology Inc. stock in 2025High-profit capital plays - jammulinksnews.com
How does MAIA Biotechnology Inc. compare to its industry peersDouble-digit growth - jammulinksnews.com
When is the best time to buy MAIA Biotechnology Inc. stockBest Stocks for Capital Safety - Newser
Is MAIA Biotechnology Inc. Stock Overbought or Oversold RSI Indicator AnalysisPredictable Return Stock Picks - Newser
How MAIA Biotechnology Inc. stock performs during market volatilityMinimized Risk Trading Plan - Newser
What drives MAIA Biotechnology Inc. stock priceTurbocharged investment results - PrintWeekIndia
How high can MAIA Biotechnology Inc. stock price go in 2025Rapid portfolio appreciation - jammulinksnews.com
MAIA Biotechnology Inc Stock (MAIA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Cap:
|
Volume (24h):